David E Bogle

Title: Innovations of David E. Bogle: A Focus on Tartrate Salts and Pharmaceutical Applications

Introduction: David E. Bogle, an accomplished inventor based in Jewett City, Connecticut, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he demonstrates a deep focus on innovative compositions that have implications for drug development.

Latest Patents: His latest patents revolve around the tartrate salts of 5,8,14-triazatetracyclo[10.3.1.00]-hexadeca-2(11),3,5,7,9-pentaene. The inventions specifically detail the L-tartrate salt and its various polymorphs, including distinct anhydrous forms (Forms A and B) and a hydrate form (Form C). In addition, the patents also explore the D-tartrate salt and its polymorphs, as well as the D,L-tartrate and meso-tartrate salts and their respective polymorphs, showcasing a comprehensive approach to pharmaceutical formulations.

Career Highlights: David E. Bogle is currently affiliated with Pfizer Corporation, a global leader in pharmaceutical innovation. His role at Pfizer has allowed him to develop and refine his patents, contributing to advancements in drug compositions that may enhance therapeutic efficacy.

Collaborations: Throughout his career, Bogle has worked alongside esteemed colleagues such as Peter Robert Rose and Glenn R. Williams. Their collaborations signify the collaborative spirit that thrives in pharmaceutical research and development, furthering the boundaries of scientific exploration.

Conclusion: David E. Bogle's work exemplifies the spirit of innovation within the pharmaceutical industry. His patented inventions not only contribute to the scientific community but also hold the potential to impact patient outcomes positively. As he continues to advance his research, Bogle remains a prominent figure in the realm of pharmaceutical inventions.